09/18/2024 3:18 PM | Haemonetics (Issuer) Miller Laurie A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 3:20 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 5:04 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 5:05 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024 3:23 PM | Haemonetics (Filer)
| Form 8-K/A | |
07/29/2024 4:03 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:29 PM | COYLE MICHAEL J (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/26/2024 3:30 PM | Bryant Diane M (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:32 PM | ABERNATHY ROBERT E (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:34 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:21 PM | Haemonetics (Issuer) Zane Ellen M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 8:47 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 3:10 PM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2024 3:27 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2024 3:25 PM | Haemonetics (Subject) Lingamneni Anila (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024 3:42 PM | Haemonetics (Subject) Lingamneni Anila (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 5:30 AM | Haemonetics (Filer)
| Form DEFA14A | |
06/07/2024 5:31 AM | Haemonetics (Filer)
| Form ARS | |
06/07/2024 5:26 AM | Haemonetics (Filer)
| Form DEF 14A | |
05/29/2024 4:42 PM | Haemonetics (Issuer) Llorens Josep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:44 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:27 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:31 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:35 PM | Haemonetics (Issuer) Miller Laurie A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:38 PM | Basil Michelle L (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 3:06 PM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 10:06 AM | Basil Michelle L (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 9:24 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024 5:03 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 4:49 PM | Galvin Roy (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:52 PM | Haemonetics (Issuer) Llorens Josep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:55 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:58 PM | Haemonetics (Issuer) Miller Laurie A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 5:01 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 5:05 PM | Haemonetics (Issuer) Maunsell Farris Maryanne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:41 PM | DArecca James (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:46 PM | Basil Michelle L (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:38 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 10:13 AM | Basil Michelle L (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 10:24 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 9:45 AM | Haemonetics (Subject) Llorens Josep (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
05/20/2024 5:16 AM | Haemonetics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
05/17/2024 4:11 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 3:52 PM | DArecca James (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 3:55 PM | Haemonetics (Issuer) Llorens Josep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 11:15 AM | Basil Michelle L (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 9:07 AM | Haemonetics (Subject) Llorens Josep (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 11:57 AM | Haemonetics (Subject) Llorens Josep (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 11:12 AM | Basil Michelle L (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 11:15 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024 5:04 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:21 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/06/2024 1:08 PM | Haemonetics (Subject) Lingamneni Anila (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 3:18 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 7:01 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 3:44 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:10 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 2:28 PM | Haemonetics (Subject) Neuberger Berman Group LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 4:49 PM | Capital Research Global Investors (Filed by) Haemonetics (Subject)
| Form SC 13G/A | |
02/08/2024 9:21 AM | Haemonetics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/08/2024 5:05 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/08/2024 5:06 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
12/12/2023 5:09 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:36 PM | Galvin Roy (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 5:19 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 5:16 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |